Advertisement

PentaVision

Glaucoma Physician

Article

The Latest Step in Glaucoma Drainage Device Evolution

New World Medical’s new nonvalved tube provides surgeons with greater control, flexibility, and expanded options for a wider range of glaucoma patients.

Rene Luthe
Glaucoma Physician November 1, 2025 Page(s): 23-24

Clinical Scorecard: The Latest Step in Glaucoma Drainage Device Evolution

At a Glance

CategoryDetail
ConditionGlaucoma
Key MechanismsNonvalved glaucoma drainage device with a smaller-diameter tube to regulate aqueous flow and reduce complications.
Target PopulationGlaucoma patients requiring drainage surgery, including those with high intraocular pressure.
Care SettingOphthalmic surgical settings.

Key Highlights

  • Ahmed ClearPath ST features a 60% smaller tube diameter compared to the original device.
  • Includes a prethreaded 6-0 Prolene ripcord for better control of aqueous flow.
  • Offers two tube sizes and two plate sizes for customizable surgical options.
  • Potentially reduces complications such as hypotony and corneal endothelial cell loss.
  • Facilitates earlier intervention in glaucoma disease progression.

Guideline-Based Recommendations

Diagnosis

  • Assess intraocular pressure and disease progression in glaucoma patients.

Management

  • Consider Ahmed ClearPath ST for patients requiring drainage surgery.

Monitoring & Follow-up

  • Monitor intraocular pressure postoperatively to ensure effective flow regulation.

Risks

  • Be aware of potential complications such as hypotony and corneal endothelial cell loss.

Patient & Prescribing Data

Patients with glaucoma, including those with high intraocular pressure and less advanced disease.

The device allows for quicker postoperative pressure management without the need for ligation.

Clinical Best Practices

  • Utilize the prethreaded ripcord for efficient flow management during surgery.
  • Select appropriate tube and plate sizes based on individual patient anatomy and needs.
  • Consider early surgical intervention in glaucoma patients with the ClearPath ST.

References